Search Results 561-570 of 17678 for SC

  1. Gastroenterology and Hepatology - Clinical trials

    The purpose of this study is to assess the pharmacodynamics (PD) of HM15211 after administration of multiple subcutaneous (SC) doses compared to placebo on ...

  2. Publications - Christopher Marquez, M.D. - Mayo Clinic

    2017 Jun; 63(6):1174-1175. View PubMed; Kulkarny VV, Wiest NE, Marquez CP, Nixon SC, Valenzuela CF, Perrone-Bizzozero NI. Opposite effects of acute ethanol ...

  3. A Study To Evaluate The Effectiveness And Safety Of Benralizumab In Patients With Hypereosinophilic Syndrome (HES) - Mayo Clinic

    ... SC injection Q4W in patients with hypereosinophilic syndrome (HES). This study comprises 2 distinct periods (together defined as the 'main study'): A 24 ...

  4. Gastroenterology and Hepatology - Clinical trials

    The purpose of this study is to assess the pharmacodynamics (PD) of HM15211 after administration of multiple subcutaneous (SC) doses compared to placebo on ...

  5. Publications - Sami Alasfar, M.D., M.P.H. - Mayo Clinic

    ... SC, Abuzeineh M, Brennan DC, Alasfar S. Donor-derived Cell-free DNA Kinetics Post-kidney Transplant Biopsy. Transplant Direct. 2021 Jun; 7 (6):e703 Epub ...

  6. Internal Medicine Residency (Florida) - Meet Our Residents

    Coral Holt, M.D.. Hometown: Myrtle Beach, SC. Medical School: University of South Carolina School of Medicine Greenville. About me: Growing up at the beach, I ...

  7. Nonalcoholic Steatohepatitis (NASH) Clinical Trials - Mayo Clinic Research

    ... (sc) to adult subjects with suspected or confirmed diagnosis of noncirrhotic nonalcoholic steatohepatitis (NASH) with no fibrosis to moderate fibrosis ...

  8. Dose Ranging Study Of Lunsekimig Compared With Placebo-control In Adult Participants With Moderate-to-severe Asthma - Mayo Clinic

    ... SC lunsekimig in adult participants aged 18 to 80 years, (inclusive) with moderate-to-severe asthma. Participation eligibility. Participant eligibility ...

  9. A Study to Investigate Mepolizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis - Mayo Clinic

    The purpose of this randomized, double-blind study is to investigate the efficacy and safety of mepolizumab (300 milligram [mg] administered subcutaneously [SC] ...

  10. Publications - Dimitar K. Gavrilov, M.D., Ph.D. - Mayo Clinic

    ... SC. Silent Tyrosinemia Type I Without Elevated Tyrosine or Succinylacetone ... SC, Caggana M, Bryant SC, Caldwell SG, Camilot M, Campbell C, Carducci C ...